|
FY2026
12 months to May 2, 2026
|
FY2025
12 months to May 3, 2025
|
FY2024
12 months to Apr 27, 2024
|
FY2023
12 months to Apr 29, 2023
|
FY2022
12 months to Apr 30, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of products sold | |||||
| Gross profit | |||||
| Selling and administrative expenses | |||||
| Goodwill impairment | |||||
| Amortization of intangibles | |||||
| Income (loss) from operations | |||||
| Interest expense, net | |||||
| Other expense (income), net | |||||
| Pre-tax income (loss) | |||||
| Income tax expense (benefit) | |||||
| Net income (loss) attributable to Methode | |||||
| Income (loss) per share attributable to Methode: | |||||
| Basic | |||||
| Diluted | |||||
| Cash dividends per share |
Loading...
